OR WAIT null SECS
March 02, 2015
Scientists and industry experts seek effective preventive therapies to combat global disease.
Proposals to make the decentralized procedure more efficient were discussed at the January 2015 EGA conference.
February 02, 2015
Manufacturers face new rules for tracing drugs through the supply chain and compounders face stricter standards.
January 02, 2015
Manufacturers are under pressure to develop pipelines, promote quality, and justify pricing.
December 02, 2014
Operational changes at FDA and CDER aim to improve global market monitoring.
November 02, 2014
Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.
Resolving the problem will require more communication between the industry and regulatory bodies.
October 02, 2014
Demand for new therapies and vaccines spotlights production challenges.
Regulatory agencies in Europe are working to harmonize the marketing approval pathway of generic medicines.
September 02, 2014
As the pharmacovigilance infrastructure becomes more entrenched in Europe, drug manufacturers are beginning to feel the burden of its high cost.